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Abstract Homology modelling is normally the technique
of choice when experimental structure data are not avail-
able but three-dimensional coordinates are needed, for
example, to aid with detailed interpretation of results of
spectroscopic studies. Herein, the state of the art of homol-
ogy modelling will be described in the light of a series of
recent developments, and an overview will be given of the
problems and opportunities encountered in this Weld. The
major topic, the accuracy and precision of homology mod-
els, will be discussed extensively due to its inXuence on the
reliability of conclusions drawn from the combination of
homology models and spectroscopic data. Three real-world
examples will illustrate how both homology modelling and
spectroscopy can be beneWcial for (bio)medical research.
Keywords Homology modelling · CASP · Spectroscopy
Introduction
Knowledge of the three-dimensional structure of proteins is
a prerequisite for much research in Welds as diverse as pro-
tein engineering, human genetics and drug design. Only
two spectroscopic techniques, nuclear magnetic resonance
(NMR) and X-ray, can produce high-resolution three-
dimensional coordinates of macromolecules. Most other
spectroscopic techniques either add information to such
three-dimensional coordinates, or require these coordinates
for detailed interpretation of their results. NMR and X-ray
are very elaborate techniques, and worldwide only about 30
protein structures are solved per day. In the time needed to
read the above abstract, on the other hand, about 50
sequences were determined (worldwide) and deposited
in international, freely and easily accessible sequence
databases. Consequently, the necessity for homology
modelling is only increasing.
In its most elementary form, homology modelling
involves calculating the structure of a protein for which
only the sequence is known using its alignment with a
homologous protein for which the structure is known.
The Wrst homology modelling articles were published as
early as the late 1970s (Greer 1980), and since then we
have kept using and improving the same concepts described
in those ground-breaking articles. The process starts with
the detection of a suitable template; an alignment is pro-
duced; insertions, deletions and residue substitutions are
performed; the model is optimized; and since the late 1990s
there is consensus that structure validation is needed to
detect the unavoidable errors in the Wnal model.
In the early 1990s many homology models were built
(and unfortunately also published; also in EBJ) just for the
sake of modelling, but since the mid 1990s homology mod-
els are considered tools that can aid with the design of
experiments and with the interpretation of their results,
although occasionally things can still go very wrong in the
literature.
G-protein-coupled receptors (GPCRs) are by far the
most important target for the pharmaceutical industry, and
due to the scarcity of GPCR structure data these are also the
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most frequently modelled molecules. Until August 2000
GPCR models were either built ab initio, or using the non-
homologous bacteriorhodopsin as a homology modelling
template. In August 2000 the structure of bovine opsin
became available (Palczewski et al. 2000), and since then
GPCR homology modelling has been a serious possibility.
GPCR models built before that historical moment are better
forgotten (Oliveira et al. 2004). Unfortunately, people kept
building, using and publishing ab initio models even after
the bovine opsin structure became available (Orry and Wal-
lace 2000). Today, four GPCR structures are available that
can be used as template; Fig. 1 shows the principal diVer-
ences between the bovine opsin structure and the structure
of the beta-2 adrenergic receptor (Cherezov et al. 2007),
one of the recently resolved GPCR crystal structures. Long
before August 2000 the importance of GPCR structure
models for drug design triggered a very large number of
spectroscopic experiments, focussed on a variety of
aspects.
The following series of short paragraphs illustrate the
mutual relation between spectroscopy and homology mod-
elling. Most examples are drawn from the GPCR research
Weld. These examples are just illustrations and neither
imply a judgment nor pretend completeness.
Exposed residue labelling
In two studies Davison and Findlay (1986a, b) identiWed
residues that were exposed to the membrane environment
or the retinal binding site, respectively, by labeling opsin
with photoactivated L-azido-4-[125]iodobenzene. This
study was carried out long before the Wrst crystal structure
of any GPCR became available, and determining which res-
idues were labelled allowed Davison and Findlay to get a
more complete picture of the three-dimensional organisa-
tion of the opsin molecule.
Site-directed spin labelling
The group of Khorana used site-directed spin labelling to
analyse the structure and light-dependent changes of part of
GPCRs. The electron paramagnetic resonance (EPR) spec-
trum of each spin-labelled mutant was analysed in terms of
residue accessibility and mobility. In the article where they
describe the region extending from helix VII to the palmi-
toylation sites in the rhodopsin molecule (Altenbach et al.
1999; Cai et al. 1999) they concluded that this region
had extensive tertiary interactions. After Oliveira et al.
(1999)—correctly—modelled this region as a helix that
runs parallel to the membrane, the interpretation of the EPR
data could be extended signiWcantly, indicating how model-
ling can help interpret spectroscopic measurements.
Fluorescence resonance energy transfer
Turcatti et al. (1996) studied ligand–receptor interactions in
the neurokinin-2 receptor (NK2) using Xuorescence reso-
nance energy transfer (FRET). A Xuorescent unnatural
amino acid was introduced at known sites into NK2. Inter-
molecular distances were determined by measuring the
Xuorescence resonance energy transfer between the Xuores-
cent unnatural amino acids and a Xuorescently labelled
NK2 heptapeptide antagonist. A similar approach was used
to measure distances between the cholecystokinin receptor
and a natural agonist (Harikumar et al. 2002) and between
the secretin receptor and secretin analogues (Harikumar
et al. 2007). Distances obtained were used as constraints to
improve models for ligand–receptor interactions. The NK2
results were interpreted in terms of an obviously very poor
bacteriorhodopsin structure. Looking at their results more
than 10 years later, and with four GPCR structures at hand,
we can see that they located the NK2 ligand largely at the
correct place. This tells us how to trust or distrust the secre-
tin FRET results and illustrates how spectroscopy can help
improve modelling.
Fourier-transform infrared spectroscopy
Molecular models of rhodopsin based upon electron density
projection maps that were constructed before the Wrst
Fig. 1 The most striking diVerence between the crystal structures of
rhodopsin (PDBid 1f88, Palczewski et al. 2006) and the beta-2 adren-
ergic receptor (PDBid 2rh1, Cherezov et al. 2007) concerns the struc-
ture and location of the extracellular loop between helix IV and V. The
loop IV–V in rhodopsin forms a -sheet that folds into the binding
pocket (yellow), whereas loop IV–V in the beta-2 adrenergic receptor
forms an -helix and extends towards the extracellular environment
(purple)Eur Biophys J (2010) 39:551–563 553
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crystal structure became available proposed a speciWc
interaction between transmembrane (TM) helices III and V,
which appeared to be mediated by amino acid residues
Glu122 and His211 on TM helices III and V, respectively.
Beck et al. (1998) used a combination of site-directed
mutagenesis and Fourier-transform infrared spectroscopy
(FTIR) to validate this hypothesis.
Small-angle scattering
Small-angle scattering has occasionally been used to assist
with homology modelling of water-soluble proteins. Mas-
carenhas et al. (1992) studied crotoxin. The sequence iden-
tity with a template structure was generally high enough to
build a good homology model, but the structure of one
large loop remained highly ambiguous. Small-angle neu-
tron scattering data corresponded much better with one of
the two models made, thus solving this problem. Comoletti
et al. (2007) studied the structure of the neuroligins and
their complex with neurexin using small-angle neutron
scattering and small-angle X-ray scattering. A high-resolu-
tion structure of the neurexin was available but no structure
was available for the neuroligins. However, the neuroligins
have signiWcant sequence similarity with acetylcholine
esterase, making it possible to build a homology model.
Scattering from neuroligin constructs was similar to that
previously obtained from acetylcholine esterase structures
(Marchot et al. 1996), indicating that the homology model
was valid.
Fluorescent ligands
Turcatti et al. (1995) studied the NK2 receptor using a
number of Xuorescent ligands, diVering only in the length
of the spacer between the Xuorescent probe and the peptide
ligand. By analyzing the diVerent levels of Xuorescence
related to the spacer lengths they found that the binding
pocket of the NK2 receptor was buried at a depth of
5–10 Å.
Modelling and spectroscopy of the M13 protein
The Wnal example to illustrate the never-ending love story
of modelling and spectroscopy was recently reviewed by
the Hemminga group. In a beautiful review (Vos et al.
2009) entitled “From ‘I’ to ‘L’ and back again: the odyssey
of membrane-bound M13 protein” they illustrate how a
large series of spectroscopic techniques have been
employed worldwide over a period of more than 20 years to
continuously update the structure model of the M13 protein
in its membrane-bound form. The (mainly spectroscopic)
techniques used during this whole odyssey include NMR,
site-speciWc and other solid-state NMR, X-ray Wbre diVrac-
tion, cryo-electron microscopy, site-directed spin labelling
and site-directed introduction of Xuorescence probes, simi-
lar to that described above for the GPCR studies, Xuores-
cence energy transfer, site-speciWc infrared dichroism etc.
Throughout this odyssey of Hemminga and others, homol-
ogy modelling and spectroscopy were both applied. This
example nicely illustrates the importance of homology
modelling for spectroscopy, and vice versa. In some cases
the spectroscopic results triggered the need to analyse the
model, while in other cases the model suggested the spec-
troscopic experiments, and in some cases both went hand in
hand. Throughout this odyssey, the model improved and
the spectroscopy became more sophisticated.
The M13 odyssey also shows that spectroscopic tech-
niques developed over the years, allowing for continuously
more precise and more accurate measurements. At this
same time homology modelling improved too. In the next
paragraphs we will discuss the latest developments in
homology modelling and its remaining unsolved problems.
We will also illustrate the usefulness of homology models,
sometimes in combination with spectroscopic techniques,
with a few real-world examples.
Method overview: the eight steps of homology 
modelling
Homology modelling is usually described as a multi-step
process in which the number of steps typically varies from
X to Y. Here we use an eight-step plan (Fig. 2). Over the
years each of these eight steps has undergone extensive
scrutiny and has been the topic of much research. Conse-
quently, models built today with a fully automatic web
server are considerably more accurate than the Wrst model-
ling approach used four decades ago by Browne et al. using
wire and plastic models of bonds and atoms (Browne et al.
1969).
Here, we will discuss the latest innovations and develop-
ments in each of the eight homology modelling steps.
Step 1: Template recognition and initial alignment
Traditionally, the modelling template is found by performing
a BLAST (Altschul et al. 1990) search against the Protein
Data Bank (PDB) (Berman et al. 2003). This approach is
often successful when the query is highly similar to struc-
tures in the database. In contrast, templates that are close to
the possible homology modelling threshold are harder to Wnd
or may even remain undetected (Sander and Schneider
1991). The development of PSI-BLAST (Altschul et al.
1997) and fold-recognition methods (e.g. Jones 1999)554 Eur Biophys J (2010) 39:551–563
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improved the detection of these diYcult-to-Wnd templates
because these methods use a proWle instead of a single
sequence to search the database. Furthermore, the growing
number of structures collected in the PDB makes it every
year easier to Wnd a homologous one.
Finding the best possible template is not limited to
searching the PDB with (PSI-)BLAST. There may be sev-
eral candidate templates with similar sequence identities to
the query. In that case, the optimal template must be
selected based on other criteria. The X-ray resolution is,
although frequently used as such, only a limited measure of
structure quality because it says something about the exper-
imental data, not about the quality of the structure model.
I.e. with 1.8-Å data one can typically make a better struc-
ture model than with 2.2-Å data, but whether or not this
better structure model is actually made depends on the crys-
tallographer and the software used.
The crystallographic residual, the so-called R-factor,
says something about the correlation of the structure model
with the experimental data and therefore seems more indic-
ative than the X-ray resolution alone. Unfortunately,
acceptable and even seemingly encouraging R-factors can
be attained by adding more parameters to the structure
models, eVectively over-Wtting/over-reWning the model
(Brändén and Jones 1990). This problem was solved by the
introduction of the free R-factor (Brünger 1992), which is
much more robust against over-Wtting because the value is
calculated only with the fraction of the X-ray data that was
not used to build the structure model. Therefore, R-free can
be seen as a description of how well the structure model
predicts an ‘independent’ measurement.
While very robust, the free R-factor is a global indicator:
it describes the structure model as a whole, but not a partic-
ular part of the protein that may interest us. A local measure
of Wt with the experimental data is needed, for instance, the
real-space R-factor (Jones et al. 1991). For PDB entries
these values can be obtained from the electron density
server (EDS) (Kleywegt et al. 2004).
So, with the X-ray resolution, the (free) R-factor and the
real-space R-factor, one can select a proper template from
the (PSI-)BLAST results. That is, one can select a template
that corresponds well with the X-ray experiment. A more
in-depth analysis of the template structure is needed to see
whether it also corresponds to our current knowledge of
protein structures. Structure validation scores such as the
Ramachandran Z-score (Hooft et al. 1997), the fraction of
Ramachandran plot outliers (Laskowski et al. 1993), side-
chain rotamer normality scores (Hooft et al. 1996a), residue
Fig. 2 The eight steps of homology modelling. The Wrst step involves
Wnding a suitable homologous protein whose structure can be used as
a modelling template, and generating the initial alignment between that
template and the model sequence. In step 2 this alignment is reWned
using, for example, knowledge obtained from the template structure. In
step 3 the backbone is generated and deletions are performed so that,
temporarily forgetting insertions, the backbone of the template looks
like that of the model as much as possible. In step 4 gaps in the model
are closed, and optionally loops are constructed ab initio. In step 5, the
side-chains are added using rotamer libraries to Wnd the best rotamer
for that local backbone conformation. Step 6 consists of molecular-
dynamics simulation of the complete model in order to remove (the
majority of) the introduced errors. In step 7 the model is checked for
remaining errors using validation software. Depending on the outcome
of the validation step we either approve the model or iterate the mod-
elling process (step 8) starting from steps 1–6Eur Biophys J (2010) 39:551–563 555
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packing scores (Vriend and Sander 1993), hydrogen-bond
network quality (Hooft et al. 1996b) and many others are used
to obtain insight into the geometric quality of the template
structure. Most of these validation scores, both global and
local, can be obtained via the PDB and the linked databanks.
Another possible step in template selection is optimisa-
tion of the template before the actual modelling. We have
recently shown that validation scores such as the Rama-
chandran Z-score and the number of atomic clashes
(bumps) can be improved by a fully automated re-reWne-
ment of the PDB entry with its original experimental data
(Joosten et al. 2009). In addition, the crystallographic R-
factor, or rather the free R-factor, is also improved by this
re-reWnement. This optimisation is particularly useful for
templates that will be used for drug docking studies
because their success often depends critically on the quality
of the atomic model. The beneWt of re-reWnement is tightly
correlated with sequence identity between the template and
the model sequence. That is, any improvement of the
atomic coordinates of a residue is lost when this residue (or
just its side-chain) has to be rebuilt. Fortunately, even with
low sequence identity, there may be regions of the template
that are not changed in the modelling process and thus can
be improved by re-reWnement.
Of course, when suYcient central processing unit (CPU)
time is available to the modeller, it may be beneWcial to use
a number of (re-reWned) PDB entries as templates, instead
of a single one.
Step 2: Alignment correction
Having identiWed one or more possible modelling templates
using the initial screening described above, more sophisti-
cated methods are needed to arrive at better alignment.
Molecular class-speciWc information systems (MCSISs)
can be a great asset in the homology modelling process.
MCSISs contain a large amount of heterogeneous data on
one particular class of proteins. The GPCRDB (http://
www.gpcr.org/7tm/; Horn et al. 2003) is a good example of
such a system. It contains sequences, structures, mutation
data, ligand binding data and much more. All of this infor-
mation is used (directly or indirectly) for creating sequence
proWles for GPCR (sub-)families. ProWle-based alignments
(Oliveira et al. 1993) are used to generate alignments that
are of signiWcantly higher quality than alignments gener-
ated by automatic methods based solely on sequence data.
Currently, MCSISs are available for only a small number of
protein families and therefore in most cases other sequence
alignment tools are needed.
Many programs are available to align a number of
related sequences, for example, CLUSTALW (Thompson
et al.  1994). The resulting multiple sequence alignment
implicitly contains a lot of additional information. For
example, if at a certain position only exchanges between
hydrophobic residues are observed, it is highly likely that
this residue is buried. Multiple sequence alignments are
also useful to place deletions or insertions in areas where
the sequences are strongly divergent. To consider this
knowledge during the alignment, one uses the multiple
sequence alignment to derive position-speciWc scoring
matrices, which are also called proWles (e.g. Taylor 1986;
Dodge et al. 1998). In recent years, new programs such as
MUSCLE and T-CoVee have been developed that use these
proWles to generate and reWne the multiple sequence align-
ments (Edgar 2004; Notredame et al. 2000).
When building a homology model, we are in the fortu-
nate situation of having an almost perfect proWle: the
known structure of the template. We simply know that a
certain alanine sits in the protein core and must therefore
not be aligned with a glutamate. Alignment techniques such
as SSALN make use of this structural knowledge found in
the template (Qiu and Elber 2006).
Step 3: Backbone generation
Aligned residues occupy the same position in the template
and model. Coordinates can thus simply be copied over to
create the initial model backbone. In practice, there are
many ways to improve this crude recipe. First, the template
is likely to be present more than once in the PDB (e.g. a
bundle of NMR structures, multiple copies in the crystal, or
solved multiple times under diVerent conditions). Here, one
can use structure validation tools (Hooft et al. 1996a, Las-
kowski et al. 1993), such as the PDBREPORT databank
(http://www.cmbi.ru.nl/gv/pdbreport/) to pick the best one,
correcting errors where possible. Second, one can combine
multiple templates, because residues missing in one tem-
plate can sometimes be found in the other, or because the
alignment covers more than one template, which is com-
mon for multi-domain targets. The well-known Swiss-
Model server (http://swissmodel.expasy.org/; Arnold et al.
2006) selects fragments from diVerent PDB Wles that
locally are most similar to the corresponding model frag-
ment. The Zhang (http://zhang.bioinformatics.ku.edu/
I-TASSER/; Pandit et al. 2006) and Robetta (http://robetta.
bakerlab.org/; Chivian et al. 2003) modelling servers have
successfully extended this concept and are today among the
best homology modelling servers available online. Some
methods do not even create a single backbone at all; instead
they use the alignment to derive restraints (hydrogen bonds,
backbone torsion angles etc.), and only later build the
model, while trying to satisfy the restraints (Sali and
Blundell 1993).
Step 4: Loop modelling
Any insertion or deletion in the alignment implies a struc-
tural change of the backbone, and can thus not be modelled
in the previous step. Since these changes usually take place556 Eur Biophys J (2010) 39:551–563
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outside regular secondary structure elements, their
prediction is referred to as loop modelling. There are two
major approaches to the problem: Wrst knowledge-based
methods (Michalsky et al. 2003), which search the PDB for
known loops with high sequence similarity to the target and
endpoints that match the anchor residues between which
the loop has to be inserted, and second, energy-based meth-
ods, which sample random loop conformations while mini-
mizing an energy function (Xiang and Honig 2002). Since
loops never Wt the anchor points exactly, they have to be
closed, using for example an algorithm borrowed from
robotics (Canutescu and Dunbrack 2003). In practice, a
combination of both methods is common.
Step 5: Side-chain modelling
The most successful approaches to side-chain prediction
are knowledge based. They use libraries of common side-
chain rotamers extracted from high-resolution X-ray struc-
tures (Dunbrack and Karplus 1993; Chinea et al. 1995;
Lovell et al. 2000). An essential feature of these libraries is
backbone dependence, hence they store the distribution of
the side-chain dihedral angles (1, 2 etc.) as a function of
the backbone dihedrals  and . This not only increases the
accuracy, but also helps to shrink the search space (i.e. the
possible combinations of interacting side-chain rotamers)
to a size that can be handled, for example using dead-end
elimination (Canutescu et al. 2003). The prediction accu-
racy is usually highest for residues in the hydrophobic core,
where more than 90% of all predicted 1 angles fall within
§20° of the experimental values, but signiWcantly lower for
residues on the surface where the percentage drops to 70%,
and further down to 50% for the combined 1/2 accuracy
(Canutescu et al. 2003). This is mainly caused by the elec-
trostatic and hydrogen-bonding interactions, which are
partly solvent mediated and much more diYcult to get right
than the simple repulsive van der Waals interactions in the
core, but also partly due to the fact that Xexible side-chains
on the surface tend to adopt multiple conformations, which
are additionally inXuenced by crystal contacts, so there sim-
ply may not be a single correct conformation at all. Never-
theless, the surface residues are among the most important
ones to get right; they mediate all the interactions, and
applications such as drug design or protein docking thus
critically depend on them.
Step 6: Model optimisation
Once all these steps are completed, one obtains the initial
homology model, which hopefully looks broadly similar to
the (usually unknown) target structure. The minor details,
however, such as the precise backbone conformation,
hydrogen-bonding networks or certain side-chain rotamers,
are often wrong. While this deWciency keeps scientists
working on experimental structure determination busy, pre-
dictors strive to bridge the gap between model and target
(the ‘last mile’ of the protein folding problem) using vari-
ous optimisation and reWnement techniques, the most prom-
inent ones being molecular dynamics (Krieger et al. 2004)
and Monte Carlo simulations (Misura et al. 2006). For a
given model, there are unfortunately many more paths lead-
ing away from the target than towards it, and combined
with the limited accuracy of empirical force Welds, this
makes it very easy to reduce the model accuracy during the
reWnement. Consequently, the best optimisation was often
no optimisation. We did well in the early Critical Assess-
ment of Structure Prediction (CASP) homology modelling
competitions simply by not performing MD simulations on
the models [except for 25 energy-minimisation steps with
CNS (Brünger et al. 1998) to introduce the same local geo-
metric features that CNS put into the real structure against
which our prediction would be compared]. Nevertheless,
steady progress over the past years has changed this rule of
thumb (see “Results”).
Step 7: Model validation
Protein structures were error free until the landmark article
on Procheck by the Thornton group (Laskowski et al.
1993). This article can be seen as the beginning of the reali-
sation that crystallographers and NMR spectroscopists
actually use experimental techniques to determine their
coordinates. With the release of the Wrst WHAT_CHECK
(Hooft et al. 1996a), structure validation became a common
household technique for most scientists and, although not at
the speed we hoped, errors in protein structures are becom-
ing less frequent. The two main bottlenecks are the intro-
duction of improved technologies in all structure solution
software used all over the world, and the fact that the detec-
tion of an error does not implicitly mean that the error can
be removed.
Step 8: Iteration
If the model is not good enough, (part of) the modelling
process has to be repeated. For instance, wrong side-chain
conformations can be improved by iterating the process
from step 5 onwards. Sometimes, this iteration step means
that one has to start the modelling process all over again
using another template or alignment. Alternatively, one can
start several modelling processes using diVerent templates.
The resulting models can be combined in the end to pro-
duce a hybrid model that consists of the strongest points of
each separate model.
Unsolved problems and future directions in homology 
modelling
While many scientiWc disciplines face huge diYculties
when trying to experimentally validate theoretical predic-
tions, protein modelling is in a fortunate situation: sinceEur Biophys J (2010) 39:551–563 557
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1994, the biennial Critical Assessment of Structure Prediction
(CASP) contests (Moult et al. 2007) have provided an ideal
opportunity to evaluate the accuracy of today’s many pro-
tein structure prediction methods. During each CASP sea-
son (lasting about 4 months once every 2 years), about 200
research groups try to predict the structures of »100 pro-
teins, the CASP targets. The target sequences are provided
to CASP by structural biology laboratories just before the
corresponding structures are solved. The predictions are
thus true blind predictions, allowing performance to be
measured on realistic test cases, locating areas of progress
as well as still unsolved problems.
CASP regularly shows that the eight homology model-
ling steps summarized above allow reliable models to be
built in many cases, from which a lot of structural and func-
tional insights can be derived. However, these eight steps
are unfortunately not suYcient to actually solve the protein
structure prediction problem via homology modelling as
soon as enough templates become available. Figure 3
shows CASP8 targets T0498 and T0499: both proteins are
56 amino acids long, 53 of which are conserved (95%
sequence identity). Still, the two structures are entirely
diVerent; just three point mutations completely change the
fold. While this is an extreme example of human protein
engineering art (He et al. 2008), also naturally occurring
proteins with similar sequences often show surprising
structural diversity (KosloV and Kolodny 2008), leading
classic homology modelling to fail miserably. The prion
protein (Prusiner 1998) and other amyloid-forming proteins
provide an even more dramatic case; here 100% identical
sequences can exist in two totally diVerent structures.
Obviously, the homology modelling problem is tightly
intertwined with the more general protein folding problem
itself. Even if a close template is available, there can always
be structurally divergent regions, which are either expected
from the poor local alignment, or unexpectedly caused by
critical point mutations, or widely diVering crystal packing
contacts.
The only way to handle these diYcult cases is to apply
more general ab initio folding algorithms, which do not
depend on template structures, but try to simulate the com-
plete folding process from the stretched-out conformation.
As it turns out, this one-algorithm-Wts-all approach is cur-
rently the most successful one at CASP (Chivian et al.
2003; Pandit et al. 2006): if available, it uses known tem-
plates (or fragments thereof) only to guide the search, but
does not depend on them. As a side-eVect, this allows
hybrid models to be built, combining the best parts from
multiple templates.
Despite these encouraging developments, the protein
folding problem is far from solved. The best models are
still built by those who got the alignment right in the Wrst
place, which unfortunately implies that structural diversity
is often missed: one cannot yet ignore the diYcult-to-align
regions and simply predict them with ab initio folding
instead. The sequence alignment problem will thus remain
an active research Weld for years to come.
Noteworthy progress has been made with model optimi-
sation to bridge the structural gap between initial model and
target. While in the early days of CASP, predictors were
well advised to keep the backbone of their model Wxed (the
frozen-core approach), simply because the danger of messing
Fig. 3 Comparison of CASP8 
targets T0498 and T0499. The 
sequences of both proteins are 
95% (53 of 56) identical (only 
residues 20, 30 and 45 diVer), 
yet the structures are totally 
diVerent. Classic homology 
modelling predicted T0499 
correctly (which looks like the 
related homology modelling 
templates in the PDB), but failed 
completely for T0498. Since the 
structures of T0498 and T0499 
have not been released yet, this 
Wgure is based on a closely 
related pair with PDB IDs 2jws 
and 2jwu from the same authors, 
who showed by NMR 
spectroscopy that these two 
structures look essentially the 
same as T0498 and T0499 
(He et al. 2008)558 Eur Biophys J (2010) 39:551–563
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up the model was too large, the situation is quite diVerent
today: force Weld accuracy (Krieger et al. 2004) and sam-
pling eYciency (Misura et al. 2006) have improved to a
level that allows well-performing methods such as Model-
ler-CSA (Joo et al. 2008), Rosetta (Chivian et al. 2003),
undertaker (Vriend 1990) and YASARA (Krieger et al.
2009) to free all atoms during the reWnement, often moving
models considerably closer to the target.
While homology modelling currently focusses on the
protein in a model, other entities, i.e. carbohydrates,
small molecules and ions, also make up important parts
of certain proteins and protein complexes; for instance,
zinc atoms in so-called zinc Wngers are important for the
stability of the protein, and the common protein haemo-
globin would be useless without its heme groups and the
iron atoms therein. Carbohydrates in glycoproteins per-
form numerous functions, ranging from providing stabil-
ity to signalling and labelling for intracellular transport
(Lütteke 2009). The many roles of non-protein entities
make it obvious that homology modelling should look
beyond the protein. A complete model should thus be
more than a three-dimensional (3D) representation of an
amino acid sequence. One major challenge for homology
modelling is recognising binding sites for non-protein
entities.
Drug docking software (e.g. Rarey et al. 1996;
Nabuurs et al. 2007) can be used to detect the binding
sites of compounds such as heme groups or coenzymes.
However, relevant biological information is needed to
select compounds that may be bound to the protein.
Copying the binding site from the template structure is
the simplest method, but does not work for ab initio
folding models. For such models, spectroscopic analysis
of the protein can provide insight into which compounds
are bound. This approach is not limited to homology
modelling; X-ray crystallography can also beneWt from
spectroscopic analysis of a protein to identify a bound
compound (Chen et al. 2002).
Incorporating ions can be an additional step of the mod-
elling process. Nayal and Di Cera (1996) have suggested a
method to detect sodium binding sites in protein structures
which can be extended to detect various other ion binding
sites. Of course, any additional experimental data can guide
this ion-site detection process. Especially tightly bound
functional ions that co-purify with the protein can be
detected by means of spectroscopic analysis. A signiWcant
number of PDB Wles have bound ions or water molecules
that were erroneously assigned. We have observed H20, and
Na+, K+, Mg2+, Ca2+ and NH4
+  ions that should actually be
one of the others in this list. This is the result of X-ray spec-
troscopy having diYculties distinguishing between H2O,
NH4
+, N a + and Mg2+ because these entities have equally
many electrons, as do K+ and Ca2+.
The power of force-Weld-based model optimisation
methods can be signiWcantly reduced when such problems
include a diVerence in the ionic charge. It is therefore very
important to (experimentally) validate the ions in template
structures when these are important for the Wnal homology
model.
Carbohydrates can be modelled at the Wnal stage of
the homology modelling process, but this does not
always reXect the protein folding process. Carbohy-
drates are not only added in post-translational modiWca-
tion (that is, when the protein is ‘done’), but also during
the protein expression by the ribosome. They are impor-
tant in the protein folding process and the detection of
misfolded proteins (Parodi 2002). It may therefore prove
interesting to add the necessary carbohydrates to the
unfolded protein before ab initio folding. Apart from
their role in protein folding, carbohydrates are some-
times important in oligomerisation of proteins; for
instance, the neuraminidase protein from inXuenza
shows diVerent glycosylation states in its monomeric,
dimeric and tetrameric states. The carbohydrates in tet-
rameric state provide extra stability (Fig. 4) and, in the
case of the Spanish Xu inXuenza virus, resistance to tryp-
sin digestion leads to increased virulence (Wu et al.
2009). This shows the vital (and sometimes lethal)
importance of considering carbohydrates in homology
models.
Fig. 4 Tetrameric form of whale inXuenza neuraminidase (PDBid
2r8h, Smith et al. 2006), coloured by monomer. Protein chains are dis-
played in ribbon representation, carbohydrate atoms in ball represen-
tation. The carbohydrates of one monomer interact with the adjacent
monomer, thus stabilising the tetramerEur Biophys J (2010) 39:551–563 559
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Results and discussion: other roles for homology 
modelling
In the 1990s most articles that included homology modelling
described just how the model of one protein was constructed,
and ended with the ominous sentence “…this model will help
us perform our research on this intriguing protein”, after
which the group would start working on something else.
Here, we will illustrate the importance of homology model-
ling for the study of inheritable diseases, but the value of
models has been amply illustrated in Welds ranging from drug
design to laundry powder enzyme engineering, from vali-
dating experimental structures to the design of humanized
antibodies, and from mutation analysis to intelligent experi-
mental design in many spectroscopic research projects.
In the following examples building the homology model
was not the ultimate goal but one of the tools used to gain
more information about a mutation, a disease or a process
in the human body. These examples prove that homology
models can be of great use in the (bio)medical Weld.
Modelling of the LRTOMT-COMT domain
In a study of non-syndromic deafness four pathogenic muta-
tions were found in an as-yet uncharacterized gene which
codes for two diVerent proteins, called LRTOMT1 and
LRTOMT2 (Ahmed et al. 2008). Three of these mutations
were mis-sense mutations located in the catechol-O-methyl-
transferase (COMT, EC 2.1.1.6) domain of LRTOMT2; one
introduced a stop codon causing the loss of a large fraction
of the protein. The COMT domain catalyses the transfer of a
methyl group from S-adenosyl-L-methionine (Ado-Met) to a
hydroxyl group of catechol. No structure for LRTOMT2
was known, so we needed a homology model to study the
mis-sense mutations in more detail.
Using the crystal structure of rat COMT [39% identity to
LRTOMT2 over 212 amino acids (PDBid 1h1d, Bonifacio
et al. 2002)] we were able to model the COMT domain of
human LRTOMT2. The three mutated residues are located in
helix 1 (p.R81Q), helix 2 (p.W105R) and the loop that
follows helix 2 (p.E110K), and thus not in the hypothetical
Fig. 5 a Molecular model of the catechol-O-methyltransferase
domain of LRTOMT2, residues 79–290. The aVected residues are
depicted in blue. The predicted ligands are coloured yellow, and the
tyrosine residue (Tyr111) that lines the hydrophobic groove of the
ligand binding site is shown in cyan. The boxed region containing res-
idues aVected by mis-sense mutations of LRTOMT2 is enlarged in
panels b–d. The helices 1 (H1) and 2 (H2) are shown with wild-type
residues Arg81, Trp105 and Glu110 depicted in blue and mutated
residues in green. Hydrogen bonds are represented by yellow dotted
lines. b The Arg81 and Glu110 residues form a salt bridge between
helix 1 and the loop following helix 2. The Gln81 residue cannot form
this salt bridge as it is not positively charged. Also, the formation of
hydrogen bonds is impaired because of the smaller size of glutamine as
compared with arginine. c The Trp105 residue is predicted to make
hydrophobic interactions as a result of its large side-chain. Most of
these interactions would be lost by the W105R substitution. d Substi-
tution E110K is predicted to lead to the loss of hydrogen bonds and a
salt bridge. There would likely be repulsion between the side-chains
Lys110 and Arg81 as both are positively charged560 Eur Biophys J (2010) 39:551–563
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substrate-binding pockets. However, the loop is predicted to
be important for the groove that binds the putative methyl
acceptor. The Arg81 and Glu110 residues are predicted to
form a hydrogen-bonded salt bridge between helix 1 and the
loop, and Trp105 is predicted to make hydrophobic interac-
tions in the core between these helices (Fig. 5). These resi-
dues may therefore be important for local protein stability
and can aVect the substrate binding region.
Modelling of the ligand-binding domain of ESRRB
Sequence analysis revealed four mis-sense mutations of the
estrogen-related receptor beta (ESRRB) gene leading to
autosomal-recessive non-syndromic hearing impairment
(Collin et al. 2008). Experimental results indicated that
ESRRB is essential for inner-ear development and function.
ESRRB encodes the estrogen-related receptor protein beta,
a member of the nuclear hormone receptor (NHR) family.
In general, members of this family share a zinc Wnger C4
DNA-binding domain at their N-terminus and a ligand-
binding domain that is located near the C-terminus. The
ligand-binding domain of nuclear hormone receptors is a
well-conserved and highly organized structure containing
12 alpha-helices. Three mutations (p.L320P, p.V342L and
p.L347P) were located within this ligand-binding domain.
The fourth mutation was located in the DNA binding
domain and will not be discussed here.
To study the three mutations in the ligand binding
domain in more detail we built a homology model of this
domain using the structure of the estrogen-related receptor
gamma (ESRRG) receptor (PDBid 1kv6, Greschik et al.
2002) as a template. It had 79% sequence identity over 229
amino acids. The molecular model showed that the three
mis-sense mutations in the ligand binding domain are likely
to aVect the structure and stability (Fig. 6). Two of the
mutations involved a leucine-to-proline mutation, L320P in
helix 7 and L347P in helix 8. In general, the introduction of
proline residues within helices reduces the stability of the
helix, and therefore these mutations will disturb the struc-
ture of the helices and probably the complete ligand-bind-
ing domain. In addition, the loss of the leucine side-chain
abrogates a number of hydrophobic interactions. The other
mutation in this domain (V342L) substitutes a leucine for a
valine residue, resulting in the occurrence of a somewhat
larger side-chain that bumps into the molecular surface of
helix one. This substitution is predicted to reduce the
strength of the interaction between helix 1 and 8.
In summary, the molecular modelling data predicts that
mutations of ESRRB will result in conformational changes
Fig. 6 a Molecular modelling 
of the ligand-binding domain of 
the human ESRRB protein. The 
structure was deduced from 
the known ESRRB structure. 
The various helices are repre-
sented by cylinders. The three 
amino acids that are aVected by 
the mis-sense mutations are indi-
cated in green. Detailed views of 
the three mutations are shown in 
panels b, c and d. The wild-type 
residue is depicted in green, 
whereas the side-chain of mutant 
residue is presented in red. 
b L320 makes hydrophobic con-
tacts in the core between two 
helices, the mutation to P causes 
loss of many hydrophobic inter-
actions. Additionally, the P will 
disturb the structure of the helix. 
c V342 is tightly packed in the 
core between two helices. This 
core will be disturbed by the 
V342L mutation because L has a 
larger side-chain. d L347P will 
cause loss of hydrophobic inter-
actions between the helices, and 
the introduction of P will disturb 
the structure of the helixEur Biophys J (2010) 39:551–563 561
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near the substituted amino acids or decreased helix stability
and are therefore likely aVect the stability and function of
the complete ligand-binding domain.
Functional states of alcohol oxidase
Van der Klei and co-workers studied four diVerent con-
formational states of the Xavoenzyme alcohol oxidase
(AO) from the methylotrophic yeasts Hansenula poly-
morpha and Pichia pastoris, including assembly inter-
mediates (Boteva et al. 1999). These proteins had to be
homology modelled from the enzyme glucose oxidase
that shows only 25% sequence identity with the AOs.
With so little similarity, homology modelling is very
diYcult and large modelling errors are to be expected.
An additional problem is that glucose oxidase is a dimer
while AO is an octamer. The low quality of the model
certainly precluded any form of protein–protein docking
to construct an octamer from the dimer. The model for-
tunately revealed a series of hydrophobic surface
patches, some of which have tryptophan residues at the
surface. As there were also tryptophans observed in the
model near the Xavin adenine dinucleotide (FAD) group,
the suggestion to apply spectroscopic techniques to
extend the modelling study came shouting from Fig. 7.
A series of spectroscopic techniques, including time-
resolved  Xuorescence,  Xuorescence anisotropy decay,
steady-state Xuorescence, and visible and near-ultravio-
let circular dichroism, was used to characterize native
AO and several putative assembly intermediates. A good
working hypothesis for the AO folding pathway could
be derived. The study also triggered the search for chap-
erones that seemed necessary to allow FAD to bind to
AO in vivo.
Conclusion
Homology modelling will always be needed because it is
impossible to solve the three-dimensional structure for
each determined sequence. An increasing number of
scientists are now using protein structures for mutational
analysis and experimental design. The process of
homology modelling has improved dramatically over the
years, but there are still many problems to solve. It is
reassuring for homology modellers that modelling
problems can often be solved using spectroscopic
techniques. Spectroscopists, on the other hand, normally
need homology models to fully harvest the results from
their spectroscopic studies. This interplay brings us back
to the title of this article: homology modelling and
spectroscopy are indeed a never-ending love story.
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